Treatment times of acute STEMI have increased with COVID-19 pandemic

Reuters Health - 23/09/2020 - Times to treatment and mortality of acute ST-segment elevation myocardial infarction (STEMI) have increased since the onset of the COVID-19 pandemic, researchers in China report. "The COVID-19 epidemic is a major global event that poses a huge challenge to the global medical system and even changes the previous treatment procedures and plans," Dr. Ming-Wei Wang of Affiliated Hospital of Hangzhou Normal University told Reuters Health by email. "We need to pay attention to the treatment of critically ill patients, because this requires a race against time to improve the prognosis." Several studies have identified treatment delays of patients with STEMI since the beginning of the pandemic, with many attributing these delays to patient reluctance to go to the hospital and to protocols initiated to stem the spread of the virus. Dr. Wang and colleagues developed a STEMI treatment process in an effort to prevent and control the epidemic...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 23 September, 202030 September, 2020